Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Belvarafenib

Generic Name: Belvarafenib

Drug Type: Small Molecule

Chemical Formula: C_₂₃H_₁₆ClFN_₆OS

CAS Number: 1446113-23-0

Unique Ingredient Identifier: 31M3WLJ3KG

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Nivolumab in Patients With NRAS-mutant Advanced Melanoma.

Phase 1

Active, not recruiting

Posted: 2021/04/08

Sponsor:Genentech, Inc.

ID:NCT04835805

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Phase 2

Recruiting

Posted: 2020/10/19

Sponsor:Hoffmann-La Roche

ID:NCT04589845

Expansion Study to Evaluate the Efficacy and Safety of HM95573 in BRAF, KRAS or NRAS Mutant Solid Cancers

Phase 1

Completed

Posted: 2017/04/18

Sponsor:

Hanmi Pharmaceutical...

ID:NCT03118817

Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics and Anti-tumor Activity of HM95573

Phase 1

Completed

Posted: 2015/04/01

Sponsor:

Hanmi Pharmaceutical...

ID:NCT02405065

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy